>>> Idenix Pharma: Fitch says Merck (MRK) buy of Idenix underscores therapeutic Idenix Pharma: Fitch says Merck (MRK) buy of Idenix underscores therapeutic add focus; expect major pharmaceutical companies will continue to consider divestitures of businesses that are not core to a business model focused on biomedical innovation